CHRISTINA FINNERTY: Open Payments
NPI 1558430918 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 51 payments from 13 companies in 2025. Trend: 2023 $593 · 2024 $534 · 2025 $818
Food & beverage: $668Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $309 |
| JAZZ PHARMACEUTICALS INC. | 2 | $184 |
| Axsome Therapeutics, Inc. | 7 | $58 |
| Xeris Pharmaceuticals, Inc. | 3 | $55 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Galderma Laboratories, L.P. | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| Medtronic, Inc. | 1 | $23 |
Products named: VRAYLAR, XYWAV, QULIPTA, INJECTAFER, Auvelity, UBRELVY, GVOKE HYPOPEN, INSPIRE.
Industry payments across ID — which companies pay providers there.
